Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome.
作者信息
Abdalla Mohnad, El-Arabey Amr Ahmed, Gai Zhongtao
机构信息
Research Institute of Pediatrics, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
出版信息
J Med Virol. 2023 Jan;95(1):e28128. doi: 10.1002/jmv.28128. Epub 2022 Sep 22.
Abstract
摘要
相似文献
1
Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome.在新冠病毒病（COVID-19）及新冠后急性综合征的背景下，高血压仍是一个动态变化的问题。
J Med Virol. 2023 Jan;95(1):e28128. doi: 10.1002/jmv.28128. Epub 2022 Sep 22.
2
Microvascular hypertensive disease, Long COVID, and end-organ pathology.微血管性高血压疾病、长期新冠后遗症与终末器官病理改变
Hypertens Res. 2023 Sep;46(9):2247-2248. doi: 10.1038/s41440-023-01205-1. Epub 2023 Jul 13.
3
Reply to: Microvascular hypertensive disease, long COVID, and end-organ pathology.回复：微血管性高血压疾病、新冠后症状及终末器官病理学
Hypertens Res. 2023 Sep;46(9):2249-2250. doi: 10.1038/s41440-023-01371-2. Epub 2023 Jul 13.
4
Post-COVID-19 diabetes in the context of long COVID.长期新冠背景下的新冠后糖尿病
Am J Emerg Med. 2022 Nov;61:208-209. doi: 10.1016/j.ajem.2022.07.015. Epub 2022 Jul 8.
5
Post-COVID syndrome, the real matter of debate.新冠后综合征，真正的争议所在。
J Med Virol. 2023 May;95(5):e28785. doi: 10.1002/jmv.28785.
6
Diagnosing post-COVID-19 condition (long COVID) in adults.成人新冠后状况（长期新冠）的诊断
CMAJ. 2023 Jan 17;195(2):E78-E79. doi: 10.1503/cmaj.220818.
7
[Post-Covid-19 syndrome: a challenge for public health?].[新冠后综合征：对公共卫生的一项挑战？]
Rev Prat. 2023 Jun;73(6):583.
8
Post COVID syndrome: a new challenge for medicine.新冠后综合征：医学面临的新挑战。
Eur Rev Med Pharmacol Sci. 2021 Jun;25(12):4422-4425. doi: 10.26355/eurrev_202106_26154.
9
Covid-19: Vaccination reduces severity and duration of long covid, study finds.研究发现，新冠疫苗接种可降低新冠长期症状的严重程度并缩短其持续时间。
BMJ. 2023 Mar 1;380:491. doi: 10.1136/bmj.p491.
10
Post-COVID or long-COVID? That is the question.新冠康复后还是长期新冠症状？这就是问题所在。
Pol Arch Intern Med. 2023 May 23;133(5). doi: 10.20452/pamw.16506.
引用本文的文献
1
Association between vaccination uptake, vaccine type, and long COVID in rural Indonesia.印度尼西亚农村地区疫苗接种率、疫苗类型与长期新冠症状之间的关联
Front Public Health. 2025 Jul 28;13:1598246. doi: 10.3389/fpubh.2025.1598246. eCollection 2025.
2
Mechanisms of long COVID: An updated review.长新冠的发病机制：最新综述
Chin Med J Pulm Crit Care Med. 2023 Dec 6;1(4):231-240. doi: 10.1016/j.pccm.2023.10.003. eCollection 2023 Dec.
3
Network analysis to explore the anti-senescence mechanism of Jinchan Yishen Tongluo Formula (JCYSTLF) in diabetic kidneys.网络分析以探究金蝉益肾通络方（JCYSTLF）对糖尿病肾病的抗衰老机制。
Heliyon. 2024 Apr 12;10(9):e29364. doi: 10.1016/j.heliyon.2024.e29364. eCollection 2024 May 15.
4
Quantifying the Adverse Effects of Long COVID on Individuals' Health After Infection: A Propensity Score Matching Design Study.量化新冠长期症状对感染后个体健康的不良影响：一项倾向得分匹配设计研究。
Risk Manag Healthc Policy. 2024 Mar 24;17:701-713. doi: 10.2147/RMHP.S446321. eCollection 2024.
5
Factors Affecting Mortality in Elderly Hypertensive Hospitalized Patients with COVID-19: A Retrospective Study.影响 COVID-19 老年高血压住院患者死亡率的因素：一项回顾性研究。
Clin Interv Aging. 2023 Nov 20;18:1905-1921. doi: 10.2147/CIA.S431271. eCollection 2023.
6
Impact of gene variations on COVID-19 pathogenicity in Pakistani patients.基因变异对巴基斯坦患者新冠病毒致病性的影响。
Saudi J Biol Sci. 2023 Oct;30(10):103813. doi: 10.1016/j.sjbs.2023.103813. Epub 2023 Sep 20.
7
COVID-19 and the cardiovascular system: a study of pathophysiology and interpopulation variability.新型冠状病毒肺炎与心血管系统：病理生理学及人群间变异性研究
Front Microbiol. 2023 Jun 7;14:1213111. doi: 10.3389/fmicb.2023.1213111. eCollection 2023.
8
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019.血管紧张素 II 在心血管疾病中的作用：双沙坦作为 2019 年冠状病毒新型治疗方法的介绍。
Biomolecules. 2023 May 2;13(5):787. doi: 10.3390/biom13050787.
Zotero 插件